RTIndie: An Art-House Catfight for the Oscars?Helen Mirren's astoundingly successful biopic "The Queen" is getting some serious competition from Pedro Almodovar's latest, as "Volver" has emerged a frontrunner for the box-office returns (and Awards Season affections) of the artsy crowd.
"The Queen," directed by Stephen Frears, was picked up in October 2005 by Miramax, who then cited the pick-up as the desire to build "an eclectic, wide-ranging slate of specialty projects." With a good-sized (at least for a studio indie) budget estimated at $15 M, it seems Miramax's acquisition of the quiet Brit royalty drama was a stroke of genius; since debuting in a scant three-theater limited release at the end of September, the film has built unrelenting momentum into a domestic gross of $10.1 M.
Of course, box-office recognition for "The Queen" has mirrored the response of critics, making it both a successful money-maker and a deserving prestige pic. That wave of laurels can be traced back to September, when it debuted to great acclaim at the Venice Film Festival and went on to win three of that festival's awards (for Best Screenplay, Best Actress, and the FIPRESCI Prize; Frears lost the Golden Lion to Zhang Ke Jia's "Still Life").
"The Queen" is currently Certified Fresh and sitting pretty at 98 percent on the Tomatometer, only three out of 120 critics having disliked it (including Stella Papamichael of the BBC, who wrote of it "The tabloid appeal is obvious, but Morgan's script is tomorrow's chip paper."). Most critics, however, agree with the Toronto Star's Peter Howell that the picture is "led by Mirren in a title role that demands Oscar glory."
But on the whole the critics are raving; it's no surprise, then, that Helen Mirren has been pegged for months as a shoe-in for Best Actress. She knows it, too; her steely, powdery visage on the film's poster screams confidence -- "It's mine, all you other actresses get out of my way!" -- a statuette finally in her hands, after two previous unrealized nominations (for "The Madness of King George" in 1995, and "Gosford Park" in 2002). Plus, Mirren's on a royal roll, having just won an Emmy for playing another Elizabeth, Elizabeth I, in the acclaimed 2005 HBO miniseries.
But last weekend a contender emerged to threaten Helen Mirren's near-lock on the Best Actress award. And her name is Penelope.
Penelope Cruz, carrying an equally strong ensemble piece, is simply luminous in "Volver," a quasi-magical tragicomedy by Spanish director Pedro Almodovar released by Sony Pictures Classics last week. Like "The Queen," "Volver" has reaped praise from critics the world over. And although it only just opened in limited release in the U.S., it's also poised to make big bucks -- and make it's leading lady a strong candidate for Oscar.
A foreign film after all, "Volver" premiered in Almodovar's native Spain last March and proceeded to rake in the dough on its tour across Europe, Latin America, and other markets. It also hit up the festival circuit -- Almodovar is a certified auteur, and proved so by nabbing a Best Screenplay award at this year's Cannes, (although he lost the Palme d'or to Ken Loach's IRA drama "The Wind That Shakes the Barley"). His film also won the festival's Best Actress prize -- a shared honor awarded to the six female leads of "Volver."
"Volver" is no slouch when it comes to the Tomatometer, either; it's currently at 93 percent, with 60 reviews. And what of the numbers?
Since debuting this spring overseas, the Almodovar film has grossed $61.5 M worldwide; last weekend it posted "Queen"-like numbers, averaging $40,400 per screen in only five theaters (when "The Queen" debuted in three theaters this fall, it took in a similar $40,671 per site). On November 22 "Volver" will hit 20 more theaters, with more and more playdates as its platform release continues -- and, you can be sure, as it keeps filling seats.
All of this is has set Oscar-watchers abuzz, as Cruz -- certainly known to American audiences, albeit for eye-candy roles and the spectacle of a Spanish beauty circulating in Hollywood -- seems a compelling Best Actress alternative to Mirren. As the beleaguered yet beautiful young mother Raimunda, Cruz's performance is revelatory; IGN Movies critic Todd Gilchrist muses "she is strong, weak, tender, tough, sexy, and maternal, often all at once." Slant Magazine writer Ed Gonzalez writes "?Mildred Pierce' won Joan Crawford an Oscar, and Almodóvar's quaint riff on the Michael Curtiz classic may do the same for Penélope Cruz."
The LA Times' Gold Derby columnist Tom O'Neill calls Mirren "the Best Actress frontrunner" but also that "Penelope Cruz has The Babe Factor in a race crowded with older gals." And while these two are certainly reigning over awards contention right now, a handful of other names have been thrown into the ring, including four-time nominee Kate Winslet for "Little Children," multiple-time nominee and twice-winner Meryl Streep for "The Devil Wears Prada," and three-time nominee Annette Bening (for the critical dud "Running With Scissors."
But there's plenty of time left in the year for more nominees, and a trio of forthcoming flicks have more potential Best Actress-worthy thesps: Dame Judi Dench, for "Notes on a Scandal" (December 25), her co-star Cate Blanchett for Steven Soderbergh's "The Good German" (December 15), and -- surprise, surprise -- Chinese actress Gong Li for "Curse of the Golden Flower," the forthcoming period epic from Zhang Yimou (December 22).
Li's entrance into the speculative arena is the most recent, and the most interesting; with turns in her first two American movies within the last year ("Memoirs of a Geisha," "Miami Vice") Li has certainly bumped up her exposure stateside. Plus, anyone remotely familiar with Chinese cinema knows she has the skills to be in contention (see "Raise the Red Lantern," "Ju Dou," or any other films she made with director Yimou). But "Curse of the Golden Flower," to be released by Sony Pictures Classics, will have the barriers of language and culture to overcome, and while the same can be said of Almodovar, Cruz, and "Volver," it will certainly be a bigger hurdle for Yimou, Li, and "Flower."